Chart: Revenue Breakdown for Novavax. Values in USD billions. In Q2 2026: Revenue 0.057, Gross Profit 0.043, Operating Income -0.055.
Revenue Flow
Chart: Revenue Flow for Novavax. Q2 2026, values in USD. Revenue 1140%, Gross Profit 840%, Cost of Revenue 280%, Net Income -1060%, Operating Income -1100%.
Balance Sheet
Chart: Balance Sheet for Novavax. Values in currency. In Q2 2026: Total Assets 0.956, Total Liabilities 1.146, Total Equity -0.191.
Q3 2016-Q2 2026
Cash Flow
Chart: Cash Flow for Novavax. Values in currency. In Q2 2026: Operating Cash Flow -0.075, Free Cash Flow -0.076, Capital Expenditures 0.001.